These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10561061)

  • 1. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata.
    Ruiz-Doblado S; Carrizosa A; García-Hernández MJ; Rodríguez-Pichardo A
    Int J Dermatol; 1999 Oct; 38(10):798-9. PubMed ID: 10561061
    [No Abstract]   [Full Text] [Related]  

  • 2. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

  • 3. Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report.
    Norton DJ; Cates C
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722027
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial.
    Lenze EJ; Mulsant BH; Shear MK; Dew MA; Miller MD; Pollock BG; Houck P; Tracey B; Reynolds CF
    Am J Psychiatry; 2005 Jan; 162(1):146-50. PubMed ID: 15625213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study.
    Campo JV; Perel J; Lucas A; Bridge J; Ehmann M; Kalas C; Monk K; Axelson D; Birmaher B; Ryan N; Di Lorenzo C; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2004 Oct; 43(10):1234-42. PubMed ID: 15381890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin syndrome. A common but often unrecognized psychiatric condition.
    Lantz MS
    Geriatrics; 2001 Jan; 56(1):52-3. PubMed ID: 11196339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of social anxiety disorder with citalopram.
    Varia IM; Cloutier CA; Doraiswamy PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):205-8. PubMed ID: 11853114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron-Induced Myoclonus With Escitalopram and HAART: Role of Drug Interactions.
    Kolli V; Addula M
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31364825
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram: a comprehensive review.
    Pollock BG
    Expert Opin Pharmacother; 2001 Apr; 2(4):681-98. PubMed ID: 11336616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute maniform reaction to a single dose of escitalopram in a social phobic patient--an atypical jitteriness syndrome?
    Muhtz C; Agorastos A; Kellner M
    Pharmacopsychiatry; 2009 Nov; 42(6):291-2. PubMed ID: 19924592
    [No Abstract]   [Full Text] [Related]  

  • 12. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Galactorrhoea and the use of selective serotonin reuptake inhibitors].
    Wessels-van Middendorp AM; Timmerman L
    Tijdschr Psychiatr; 2006; 48(3):229-34. PubMed ID: 16956087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.
    Amitai M; Kronenberg S; Carmel M; Michaelovsky E; Frisch A; Brent D; Apter A; Chen A; Weizman A; Fennig S
    J Neural Transm (Vienna); 2016 Nov; 123(11):1347-1354. PubMed ID: 27324805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
    Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
    Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients.
    Filteau MJ; Baruch P; Lapierre YD; Bakish D; Blanchard A
    Int Clin Psychopharmacol; 1995 Mar; 10(1):51-4. PubMed ID: 7622805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series.
    Van Ameringen M; Mancini C; Patterson B; Bennett M
    J Psychopharmacol; 2007 Jul; 21(5):472-6. PubMed ID: 17664246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram for depression.
    Med Lett Drugs Ther; 1998 Dec; 40(1041):113-4. PubMed ID: 9854566
    [No Abstract]   [Full Text] [Related]  

  • 20. Conclusions inconsistent with results with citalopram.
    Kruszewski SP
    Am J Psychiatry; 2005 Nov; 162(11):2195-6; author reply 2196-7. PubMed ID: 16263873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.